{
  "source": "intake_form",
  "faculty_id": "intake_alexander_serganov",
  "name": "Alexander Serganov",
  "name_canonical": "Alexander Serganov",
  "title": "Principal Investigator",
  "affiliations": [
    "Biochemistry and Molecular Pharmacology"
  ],
  "affiliations_raw": "Biochemistry and Molecular Pharmacology",
  "affiliations_unmapped": [],
  "lab_synopsis": "We use a combination of biophysical methods, biochemical techniques, and structural approaches, including X-ray crystallography and cryo-electron microscopy, to elucidate molecular mechanisms of fundamental cellular processes associated with biosynthesis of RNA, metabolism of RNA, and RNA-mediated gene expression control. We study Fragile X syndrome and antibiotic resistance. We design small molecule drugs to target proteins.",
  "common_experiments_raw": "X-ray crystallography, cryo-EM, biochemical assays, drug design",
  "research_keywords": [],
  "experimental_capabilities": [],
  "model_systems": [],
  "focus_groups": [],
  "publications": [],
  "id": "intake_alexander_serganov",
  "department_site": "Biochemistry and Molecular Pharmacology",
  "keywords": [],
  "summary": "We use a combination of biophysical methods, biochemical techniques, and structural approaches, including X-ray crystallography and cryo-electron microscopy, to elucidate molecular mechanisms of fundamental cellular processes associated with biosynthesis of RNA, metabolism of RNA, and RNA-mediated gene expression control. We study Fragile X syndrome and antibiotic resistance. We design small molecule drugs to target proteins."
}
